Javadi Alireza's Form 4 filing
Rani Therapeutics Holdings, Inc. (RANI) · filed Jul 21, 2026
- Accession no.
- 0002123843-26-000008
- Filed
- Jul 21, 2026, 7:24 PM ET
- Trade date
- Mar 27-Jun 27, 2026
- Filing delay
- 116 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $301.08. It was filed 116 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Javadi AlirezaCIK 0002123843 | Officer (Chief Technical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Class A Common Stock | SSaleDisposed | −386 | $0.78 | −$301.08 | 9,689 | Direct | |
| Jun 27, 2026 | Class A Common Stock | FTax withholdingDisposed | −309 | $0.74 | −$228.66 | 9,380 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.